Johnson & Johnson Sues Biden Administration Over New Medicare Drug Pricing Rules

In a significant event, the drug company Johnson & Johnson (J&J) has decided to take legal action against the Biden government due to their contentious Medicare Drug Price Discussion Program, put into place by the Inflation Reduction Act. This indicates that J&J is the third key drug company, coming after Merck & Co. and Bristol […]

Read More